Treatment of cells with a standard dose of 1 μM RG7388 for 6 h had been shown in our experiments to activate early expression of several p53 pathway genes with minimal cytotoxic effects on CLL cells at this dose and time point [2]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.